0001209191-18-038316.txt : 20180618 0001209191-18-038316.hdr.sgml : 20180618 20180618162936 ACCESSION NUMBER: 0001209191-18-038316 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180614 FILED AS OF DATE: 20180618 DATE AS OF CHANGE: 20180618 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PRYGOCKI MARK A SR CENTRAL INDEX KEY: 0001257544 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38529 FILM NUMBER: 18904983 MAIL ADDRESS: STREET 1: C/O MEDICS STREET 2: 8125 N. HAYDEN RD CITY: SCOTTSDALE STATE: AZ ZIP: 85258 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001660334 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463137900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 GARRETT STREET CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 BUSINESS PHONE: 434-980-8100 MAIL ADDRESS: STREET 1: 200 GARRETT STREET CITY: CHARLOTTESVILLE STATE: VA ZIP: 22902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-14 0 0001660334 Verrica Pharmaceuticals Inc. VRCA 0001257544 PRYGOCKI MARK A SR C/O VERRICA PHARMACEUTICALS INC. 10 NORTH HIGH STREET, SUITE 200 WEST CHESTER PA 19380 1 0 0 0 Stock Option (Right to Buy) 15.00 2018-06-14 4 A 0 17502 0.00 A 2028-06-14 Common Stock 17502 17502 D 1/3 of the total shares subject to the option shall vest on June 14, 2019 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date. /s/ Edward Sniezek, Attorney-in-Fact 2018-06-18